00739nas a2200265   4500000000100000000000100001008004100002653002700043653001700070653002100087653003300108653002500141653002000166100001600186700001600202700001100218700001100229700001200240700001400252700001500266700001500281245014800296250001500444020001400459       2023                            d10aCardiovascular disease10aCohort study10adrug utilization10aglucose-lowering medications10apharmacoepidemiology10aType 2 diabetes1 aD. Abrahami1 aE. D'Andrea1 aH. Yin1 aS. Kim1 aJ. Paik1 aD. Wexler1 aL. Azoulay1 aE. Patorno00aContemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom  a2023/07/03  a1462-8902